Concepedia

Krista Kinneer

KK

20

Publications

1.3K

Citations

17

H-Index

2002

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

AstraZeneca (United States)

Spirogen (United Kingdom)

AstraZeneca (United Kingdom)

National Institute for Occupational Safety and Health

Krista Kinneer is an author at Dana-Farber Cancer Institute specializing in medicine, immunology, and cancer research.

ORCID

Top concepts

Publications per year

2002–2024

20

Publications

20

Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap n collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction

Qiang Ma, Krista Kinneer, Yongyi Bi et al. · Biochemical Journal · 2004 · 213 citations · Full text

, , +18

A Human Antibody–Drug Conjugate Targeting EphA2 Inhibits Tumor Growth<i>In vivo</i>

Dowdy Jackson, John Gooya, Shenlan Mao et al. · Cancer Research · 2008 · 148 citations · Full text

Chemoprotection by Phenolic Antioxidants

Qiang Ma, Krista Kinneer · Journal of Biological Chemistry · 2002 · 124 citations · Full text

Inhibition of Nuclear Factor κB by Phenolic Antioxidants: Interplay between Antioxidant Signaling and Inflammatory Cytokine Expression

Qiang Ma, Krista Kinneer, Jianping Ye et al. · Molecular Pharmacology · 2003 · 108 citations

Direct targeting of αvβ3 integrin on tumor cells with a monoclonal antibody, Abegrin™

Kathy Mulgrew, Krista Kinneer, Xiao-Tao Yao et al. · Molecular Cancer Therapeutics · 2006 · 96 citations · Full text

, , +15

Rows per page

1–5 of 20